THE introduction of a new generation progestogen-only contraceptives pill, Slinda (drospirenone 4mg) is offering a new option for women, sexual health physician and University of NSW School of Women's and Children's Health, Dr Terri Foran, believes.
Foran said the medication removed concerns of rare clotting risks associated with estrogen products, noting that issues related to COVID-19 vaccine side-effects had prompted some women to rethink their contraceptive medication.
Slinda is currently available via private prescription.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 21
